Health
‘Significant humoral response’ following two COVID-19 vaccine doses in RMD patients – medwireNews
Most patients with rheumatic and musculoskeletal diseases mount a humoral immune response following receipt of the second dose…
medwireNews: Most patients with rheumatic and musculoskeletal diseases (RMDs) mount a humoral immune response following receipt of the second dose of the PfizerBioNTech (BNT162b2) vaccine against SARS-CoV-2, say researchers.
Yolanda Braun-Moscovici (Rambam…
Continue Reading
-
Noosa News23 hours agoMigration blunders lead to strike-off – Proctor
-
Business18 hours agoZip shares rocketed 32% in August. Here’s how
-
Business20 hours agoGold price alert! Macquarie reveals its top ASX 200 gold stock as the metal hits all-time high
-
Noosa News16 hours agoThe small patch of paddock emitting 10,000 cars’ worth of methane